Charles Schwab
KRMD icon

Charles Schwab’s KORU Medical Systems KRMD Stock Holding History

Charles Schwab’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$532K Buy
126,710
+18,829
+17% +$77.1K ﹤0.01% 3222
2026
Q1 		$466K Sell
107,881
-12,783
-11% -$63.4K ﹤0.01% 3120
2025
Q4 		$701K Hold
120,664
– – ﹤0.01% 3046
2025
Q3 		$462K Buy
120,664
+1,543
+1% +$5.9K ﹤0.01% 3196
2025
Q2 		$426K Buy
119,121
+106,308
+830% +$302K ﹤0.01% 3193
2025
Q1 		$32.5K Hold
12,813
– – ﹤0.01% 3434
2024
Q4 		$49.3K Hold
12,813
– – ﹤0.01% 3441
2024
Q3 		$35K Hold
12,813
– – ﹤0.01% 3449
2024
Q2 		$34K Sell
12,813
-79,915
-86% -$183K ﹤0.01% 3555
2024
Q1 		$219K Hold
92,728
– – ﹤0.01% 3225
2023
Q4 		$228K Hold
92,728
– – ﹤0.01% 3260
2023
Q3 		$250K Hold
92,728
– – ﹤0.01% 3245
2023
Q2 		$320K Buy
92,728
+79,915
+624% +$314K ﹤0.01% 3211
2023
Q1 		$54.1K Sell
12,813
-8,564
-40% -$33.7K ﹤0.01% 3336
2022
Q4 		$76.3K Hold
21,377
– – ﹤0.01% 3294
2022
Q3 		$48K Hold
21,377
– – ﹤0.01% 3338
2022
Q2 		$55K Hold
21,377
– – ﹤0.01% 3382
2022
Q1 		$62K Buy
+21,377
New +$64K ﹤0.01% 3499
2021
Q3 		– Sell
-13,520
Closed -$63K – 3528
2021
Q2 		$63K Sell
13,520
-55,928
-81% -$220K ﹤0.01% 3337
2021
Q1 		$245K Sell
69,448
-58,436
-46% -$253K ﹤0.01% 3290
2020
Q4 		$770K Sell
127,884
-9,815
-7% -$54.9K ﹤0.01% 2854
2020
Q3 		$995K Buy
137,699
+80,322
+140% +$712K ﹤0.01% 2680
2020
Q2 		$516K Buy
57,377
+44,424
+343% +$449K ﹤0.01% 2818
2020
Q1 		$98K Hold
12,953
– – ﹤0.01% 3109
2019
Q4 		$85K Buy
+12,953
New +$63.2K ﹤0.01% 3105

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $164M AUM
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
LCM
Lionhunter Capital Management New York $222M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Charles Schwab's KRMD Position: Q2 2026 in Review

Charles Schwab increased its KORU Medical Systems (KRMD) stake by 17% in Q2 2026, buying an estimated $77.1K and bringing the position to 126,710 shares worth $532K. The position accounts for ﹤0.01% of the portfolio, ranked #3222.

Charles Schwab first reported a position in KRMD in Q4 2019 and has held it in 25 quarters since. The position peaked at $995K in Q3 2020. 85 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • Charles Schwab held 126,710 shares of KORU Medical Systems worth $532K as of Q2 2026.
  • Charles Schwab bought 18,829 KORU Medical Systems shares in Q2 2026, an estimated $77.1K.
  • KORU Medical Systems made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #3222 holding.
  • Charles Schwab first reported a position in KORU Medical Systems in Q4 2019 and has held it in 25 quarters since.
  • Charles Schwab's KORU Medical Systems position peaked at $995K in Q3 2020.
  • 85 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.